September 23-24, 2026 | Part of Biotech Week Boston
Hynes Convention CenterBoston, United States Timothy DyerGlobal Business Development at NovMetaPharmaSpeaker
Profile
Timothy Dyer is Strategic Advisor, Global Business Development at NovMetaPharma Co., Ltd. (NMP), where he leads U.S. and EU partnering for the company's lead asset, Cyclo-Z. He brings more than 25 years of biopharma leadership, including senior roles at PTC Therapeutics, Tris Pharma, Edge Therapeutics, Otsuka, and Pfizer. He holds an MBA from NYU Stern and an MS in Regulatory Affairs and Quality Assurance from Temple University.
Agenda Sessions
Preserving Lean Mass in the GLP-1 Era: A First-in-Class CLIC1 Modulator Approach
, 13:40View Session